# Human Milk Oligosaccharide-Based Synbiotic Supplement for Intestinal Microbiota Dysbiosis

> **NCT06615986** · EARLY_PHASE1 · RECRUITING · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 100 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DIETARY_SUPPLEMENT:** Cardiosyn

## Key facts

- **NCT ID:** NCT06615986
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-15
- **Primary completion:** 2027-04-15
- **Final completion:** 2027-05-15
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06615986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06615986, "Human Milk Oligosaccharide-Based Synbiotic Supplement for Intestinal Microbiota Dysbiosis". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT06615986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*